Coupang Gains 3.4% as Peers Slide Into Earnings

CPNG rose 3.4% over the past week to $14.37, a notable divergence from its closest peers, which fell a median of 6.7% over the same period. MELI dropped 10.3% on the week, and AMZN shed 3.1%, making Coupang's relative resilience the most immediately actionable data point ahead of the November 3 print.

That outperformance sits against a difficult year. Coupang is down roughly 30% in 2026, and the stock trades at $14.37 against an analyst consensus target of $23.34, a gap of more than 60%. Most of the Street remains constructive: B of A Securities held its Buy rating in August, though it has trimmed its target twice this year, most recently to $24. Deutsche Bank upgraded to Buy at the same time, setting a $21.50 target. Barclays kept Overweight with a $29 target in July. The directional theme across the analyst community has been one of persistent target compression paired with ratings discipline, the Street believes in the recovery case but keeps marking down the timeline. The P/E multiple has compressed 58 points over the past 30 days, landing at 95.8x, while EPS momentum over the past 90 days ranks in the 100th percentile, meaning forward estimates have been revised sharply higher even as the share price has lagged.

The lending market gives short sellers no particular incentive to press their position. Availability is extremely loose at nearly 7,830% of short interest, meaning the pool of shares available to borrow vastly exceeds the amount currently shorted. Cost to borrow is 0.42%, down roughly 9% over the past month. Short interest itself is 4.5% of the free float, up around 4% over 30 days but down sharply from a mid-October peak near 5%, when 82.5 million shares were short. The borrow conditions tell a story of limited conviction on the bearish side rather than any building squeeze dynamic. Options positioning reinforces this: the put/call ratio is 0.21, close to its 52-week low of 0.19, well below the year's high of 0.63. Call activity dominates the options market by a wide margin heading into the release.

The ownership structure is concentrated. SoftBank's investment arm, SB Investment Advisers, holds 17.3% as last disclosed, down from 18.7%, while founder Bom Kim holds around 9.1%. Baillie Gifford's stake has been trimmed from 7.2% to 4.8% across three filings. All three are passive Schedule 13G holders; there is no activist on the register. On the insider side, the only open-market transaction in the past 90 days was a Chief Accounting Officer sale of roughly $75,000 in early October, executed under a pre-arranged 10b5-1 plan, a scheduled disposition rather than a discretionary signal.

The print will test whether Coupang's earnings-estimate upgrades, the strongest in its peer group on a 90-day basis, are translating into actual margin progress, and whether management can close the distance between a $14 stock price and a Street consensus that has stayed anchored above $20 all year despite repeated target cuts.